Guyer Charles Greg 5
5 · BIOMARIN PHARMACEUTICAL INC · Filed Feb 13, 2026
Insider Transaction Report
Form 5
Guyer Charles Greg
EVP, Chief Technical Officer
Transactions
- Award
Common Stock
[F1]2025-04-30$54.14/sh+317$17,161→ 81,155 total - Award
Common Stock
[F2]2025-10-31$45.53/sh+62$2,823→ 81,217 total
Footnotes (2)
- [F1]Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan.
- [F2]Represents the shares acquired by the reporting person on October 31, 2025, pursuant to the issuer's Employee Stock Purchase Plan.
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact|2026-02-13